Govt asks states, UTs to ensure continuous power supply at vaccine cold chain storage sites
In a letter addressed to the Additional Chief Secretary/Principal Secretary/Secretary (Power/Energy) of all States/UTs, the MoP also advised them to keep alternate standby power supply to deal with any contingencies.
ANI, New Delhi
PUBLISHED ON JAN 19, 2021 09:14 PM IST
Union Ministry of Power (MoP) on Tuesday advised all States and Union Territories to ensure uninterrupted availability of continuous and reliable power supply at all the vaccine cold chain storage points and session sites in view of the ongoing vaccination drive in the country.
In a letter addressed to the Additional Chief Secretary/Principal Secretary/Secretary (Power/Energy) of all States/UTs, the MoP also advised them to keep alternate standby power supply to deal with any contingencies.
"Government of India has been proactively taking all necessary steps for carrying out all necessary activities for the nationwide roll-out of COVID-19 vaccine w.e.f 16.01.2021 in close collaboration with all the States/UTs and all stakeholders," the Ministry of Power said.
"Further, all States/UTs are advised to also keep alternate standby power supply to deal with any contingencies," the letter said.
Noting the importance of the continuous power supply, the Ministry of Power said, "A critical element for success of the immunization drive would be the uninterrupted supply of reliable electricity at the vaccine cold chain storage points and session sites. Any kind of power cuts can have an adverse impact on the entire immunization drive."
"Hence, all States/UTs are advised to ensure uninterrupted availability of 24x7 and reliable power supply at all the vaccine cold chain storage points and session sites in their respective regions," the letter said. (ANI)
Topics
Action against Prayagraj hospital sought in alleged medical negligence case
By HT Correspondent, Prayagraj
PUBLISHED ON MAR 08, 2021 04:31 PM IST
- A three-year-old suffering from acute intestinal obstruction underwent two surgeries at a private hospital before being referred to the government-run children’s hospital. She died a few days later.
Covid-19 pandemic: WHO warns against letting guard down
Agencies, Geneva
UPDATED ON MAR 07, 2021 05:37 AM IST
“Countries are going to lurch back into third and fourth surges if we’re not careful.” Mike Ryan, WHO’s top emergency expert, told an online briefing.
Cumulative Covid-19 vaccinations cross 20-million mark: Government
By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 06, 2021 11:35 PM IST
India has administered 20,662,073 doses of the vaccine so far of which 6,972,859 healthcare workers have received the first dose and 3,522,671 have got the second dose.
Army veterans to be vaccinated from next week. All you need to know
By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
PUBLISHED ON MAR 06, 2021 11:28 PM IST
- The government, when it launched its vaccination programme on January 16, ensured that army personnel involved in active duty also get vaccinated as the nation in its first phase had decided to inoculate healthcare workers as well as frontline workers.
Study says some coronavirus mutations help it evade T-killer cells
PTI, London
UPDATED ON MAR 06, 2021 04:22 PM IST
In the current study, published in the journal Cell Immunology, the researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.
Treatment based on CRISPR can stop replication of Covid-19, flu viruses: Study
PTI, Washington
PUBLISHED ON MAR 05, 2021 04:34 PM IST
The therapy, described in the journal Nature Biotechnology, is based on CRISPR technology, which is normally used to target and edit specific portions of the genetic code -- the way that the four bases of DNA -- A, C, G and T -- are strung together.
UK Covid-19 trial finds no benefit of gout drug in hospitalised adults
Posted by Harshit Sabarwal | Reuters
PUBLISHED ON MAR 05, 2021 04:06 PM IST
An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said.
Covid-19 antibodies, vaccines less effective against virus variants: Study
Posted by Harshit Sabarwal | PTI, Washington
PUBLISHED ON MAR 05, 2021 02:33 PM IST
The research, published in the journal Nature Medicine, noted that the three fast-spreading variants of the coronavirus first reported in South Africa, the UK and Brazil, can evade antibodies that work against the original form of the virus that sparked the pandemic.
More than 1 million Covid-19 vaccine doses given in a day: Government
By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 04, 2021 11:16 PM IST
“Total 10,93,954 vaccine doses were given till 7 pm today, the forty-eighth day of nationwide COVID19 vaccination,” the health ministry said in a statement.
South Africa regulator at 'advanced' stage of Pfizer Covid-19 vaccine review
Reuters
PUBLISHED ON MAR 04, 2021 10:46 PM IST
According to the South African Health Products Regulatory Authority (SAHPRA), Pfizer's Section 21 application is in advanced stages of review. Such an application, normally valid for six months, is an instrument for emergency use access of a health product that is unregistered.
Indian study finds multiple mutations, unique proteins in coronavirus
PTI, Bengaluru
PUBLISHED ON MAR 04, 2021 04:36 PM IST
The study has also shown that the host produces several proteins of their own as their body launches an immunological defence in response to the viral attack.
Researchers identify cause, potential treatment for Covid-induced heart damage
ANI, Washington
PUBLISHED ON MAR 04, 2021 05:09 AM IST
In severe cases of Covid-19, the immune system overreacts to the infection, releasing inflammatory molecules called cytokines into the bloodstream.
Mutating Covid-19 mars optimism initially brought on by vaccines: Report
Reuters, Chicago
PUBLISHED ON MAR 03, 2021 11:12 PM IST
A new consensus is emerging among scientists, according to Reuters interviews with 18 specialists who closely track the pandemic or are working to curb its impact.
Covid-19 vaccination drive: List of eminent personalities inoculated
By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON MAR 03, 2021 08:10 PM IST
- These lawmakers are trying to address vaccine hesitancy which medical experts and lawmakers believe may impact the vaccination drive.
Covaxin shows 81% efficacy in phase 3 clinical trial: Bharat Biotech
By Rhythma Kaul
UPDATED ON MAR 04, 2021 03:44 AM IST
The vaccine is stable at 2°C to 8°C (refrigeration) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels